Download
fnins-15-695268.pdf 1,07MB
WeightNameValue
1000 Titel
  • Preferential Cochleotoxicity of Cisplatin
1000 Autor/in
  1. Prayuenyong, Pattarawadee |
  2. Baguley, David M. |
  3. Kros, Corné J. |
  4. Steyger, Peter S. |
1000 Verlag
  • Frontiers Media S.A.
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-07-26
1000 Erschienen in
1000 Quellenangabe
  • 15:695268
1000 Copyrightjahr
  • 2021
1000 Embargo
  • 2022-01-28
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.3389/fnins.2021.695268 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350121/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Abstract/Summary
  • <jats:p>Cisplatin-induced ototoxicity in humans is more predominant in the cochlea than in the vestibule. Neither definite nor substantial vestibular dysfunction after cisplatin treatment has been consistently reported in the current literature. Inner ear hair cells seem to have intrinsic characteristics that make them susceptible to direct exposure to cisplatin. The existing literature suggests, however, that cisplatin might have different patterns of drug trafficking across the blood-labyrinth-barrier, or different degrees of cisplatin uptake to the hair cells in the cochlear and vestibular compartments. This review proposes an explanation for the preferential cochleotoxicity of cisplatin based on current evidence as well as the anatomy and physiology of the inner ear. The endocochlear potential, generated by the stria vascularis, acting as the driving force for hair cell mechanoelectrical transduction might also augment cisplatin entry into cochlear hair cells. Better understanding of the stria vascularis might shed new light on cochleotoxic mechanisms and inform the development of otoprotective interventions to moderate cisplatin associated ototoxicity.</jats:p>
1000 Sacherschließung
lokal cochlea
lokal vestibulotoxicity
lokal Neuroscience
lokal cochleotoxicity
lokal ototoxicity
lokal vestibular
lokal cisplatin
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/UHJheXVlbnlvbmcsIFBhdHRhcmF3YWRlZQ==|https://frl.publisso.de/adhoc/uri/QmFndWxleSwgRGF2aWQgTS4=|https://frl.publisso.de/adhoc/uri/S3JvcywgQ29ybsOpIEou|https://frl.publisso.de/adhoc/uri/U3RleWdlciwgUGV0ZXIgUy4=
1000 Hinweis
  • DeepGreen-ID: 3e3d084bb3fd417a95a5756bb01cecea ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. Royal National Institute for Deaf People |
  2. National Institute on Deafness and Other Communication Disorders |
  3. National Institute of General Medical Sciences |
1000 Fördernummer
  1. -
  2. -
  3. -
1000 Förderprogramm
  1. -
  2. -
  3. -
1000 Dateien
  1. Preferential Cochleotoxicity of Cisplatin
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Royal National Institute for Deaf People |
    1000 Förderprogramm -
    1000 Fördernummer -
  2. 1000 joinedFunding-child
    1000 Förderer National Institute on Deafness and Other Communication Disorders |
    1000 Förderprogramm -
    1000 Fördernummer -
  3. 1000 joinedFunding-child
    1000 Förderer National Institute of General Medical Sciences |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6477996.rdf
1000 Erstellt am 2024-05-21T12:20:48.998+0200
1000 Erstellt von 322
1000 beschreibt frl:6477996
1000 Zuletzt bearbeitet 2024-05-22T09:39:17.143+0200
1000 Objekt bearb. Wed May 22 09:39:17 CEST 2024
1000 Vgl. frl:6477996
1000 Oai Id
  1. oai:frl.publisso.de:frl:6477996 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source